BIO-TECHNE Corp (TECH) stock

TECHNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends June 30

Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q/A on Nov 12, 2026Score 11/3040% above fair value

$72.80−0.02 (-0.03%)

Close on Nov 11, 2026Market cap $11.43BP/E 66.8Yield 0.44%

Bio-Techne price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Bio-Techne's price to book ratio was 5.4× on Nov 11, 2026, against 5.1× a year earlier. Over the last 5 years it ranged from 3.8× to 12.4×, with a median of 5.6×.

Price to Book Ratio at the end of each year

Period	Period end	Value	Change (pts)
2026	Nov 11, 2026	5.4×	+0.7
2025	Dec 31, 2025	4.7×	−0.7
2024	Dec 31, 2024	5.4×	−0.8
2023	Dec 29, 2023	6.1×	−1.3
2022	Dec 30, 2022	7.4×	−5.0
2021	Dec 31, 2021	12.4×	+3.9
2020	Dec 31, 2020	8.5×	+1.4
2019	Dec 31, 2019	7.1×	+2.2
2018	Dec 31, 2018	4.9×	−0.1
2017	Dec 29, 2017	5.0×	+0.8
2016	Dec 30, 2016	4.3×	+0.3
2015	Dec 31, 2015	4.0×	−0.3
2014	Dec 31, 2014	4.3×	−0.5
2013	Dec 31, 2013	4.8×	+1.1
2012	Dec 31, 2012	3.7×	−0.6
2011	Dec 30, 2011	4.3×	−0.4
2010	Dec 31, 2010	4.6×	−1.0
2009	Dec 31, 2009	5.7×	–